A 70-year-old man is diagnosed with pancreatic tumor and is successfully treated with a long-acting somatostatin analogue.

What is the most likely gastrointestinal e nd ocrine action of this treatment ?

Question

A  70-year-old   man is diagnosed with  pancreatic  tumor   and is successfully treated with a  long-acting  somatostatin analogue.

What is the  most likely   gastrointestinal   e nd ocrine  action  of  this treatment ?

Accepted Answer

inhibition of the secretion of the beta cells of pancreatic islets

Answer

increase parietal cells gastric hydrochloric acid secretion

Answer

inhibition of all the exocrine function of the gastrointestinal tract

Answer

stimulation of glucagon secretion from alpha pancreatic cells

Answer

stimulation of histamine release from enterochromaffin like cells

Crowdly